Developer docs
API playgroundTry for free, no card

Search company profiles

Sea Court Capital

Full company profile

uuid00052fr

Namestring
Sea Court Capital
Legal namestring
Sea Court Capital
Websiteurl
seacourtcapital.com
Company typeenum
Private
Founded yearint
2022
Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersGreenwich, United States
HQ citystring
Greenwich
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, healthcare technology investments, cold chain logistics, early-stage growth capital, series A funding
Industry1 code
1Corporate Strategic Real Assets & Infrastructure Venture Investing
CodeFSANAHANPrimaryYes
NAICS code1 code
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Venture Capital
No data
Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sea Court Capital is a venture capital firm that invests growth capital in early-stage companies developing cold chain logistics and healthcare technology solutions. The firm provides funding along with strategic guidance and industry connections to portfolio companies addressing temperature-controlled supply chain challenges in the pharmaceutical and healthcare sectors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sea Court Capital is an investment/capital firm that provides venture capital funding to portfolio companies. The firm does not offer a technology product or service offering. Based on the source data, Sea Court Capital led the $16.5 million Series A funding round for Ember LifeSciences in December 2025 (later expanded to $27 million in May 2026). The company operates offices in Greenwich, CT, Washington, D.C., and Los Angeles, CA.

Product and service1 record
1Early-stage venture capital investment
CategoryVenture Capital
Description

Venture capital funding deployed into early-stage companies developing cold chain logistics and healthcare technology solutions; investors receive equity stakes in exchange for growth capital.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Khosla Ventures
TypeDirect peer
Description

Large US venture firm with deep healthcare and life sciences practice alongside tech investing. Highly comparable to Sea Court Capital as an early-stage venture investor backing breakthrough healthcare and deep-tech solutions.

2ARCH Venture Partners
TypeDirect peer
Description

Premier early-stage healthcare and life sciences venture firm that leads Series A rounds in biotech, pharma services, and healthtech infrastructure. Comparable to Sea Court Capital in leading thesis-driven healthcare investments at the Series A stage.

3Flagship Pioneering
TypeDirect peer
Description

Venture firm that creates and funds breakthrough healthcare and biotech companies, with strong orientation toward platform innovations in pharma supply chain and life sciences infrastructure. Directly comparable to Sea Court Capital's healthcare-vertical thesis.

4General Catalyst
TypeDirect peer
Description

Multi-stage venture firm with a substantial healthcare practice (Health Assurance) that invests in early- and growth-stage healthcare and pharma-services companies. Comparable as a thesis-driven VC backing healthcare logistics and infrastructure plays.

5Section 32
TypeDirect peer
Description

Healthcare-focused venture fund investing in frontier healthtech, biotech, and pharma infrastructure at the Series A stage. Comparable to Sea Court Capital in leading specialized healthcare Series A rounds.

6Bessemer Venture Partners
TypeBroad incumbent
Description

Large multi-stage venture firm with a long-standing healthcare practice covering biotech, healthtech, and pharma services. Comparable as a healthcare-active VC, though broader in sector scope than Sea Court Capital's cold chain focus.

7Andreessen Horowitz (a16z Bio + Health)
TypeBroad incumbent
Description

Major venture firm with a dedicated bio/health fund investing in biotech, digital health, and healthcare infrastructure. Comparable as a healthcare-vertical lead investor, but operates at materially larger fund scale than Sea Court Capital.

8Lux Capital
TypeDirect peer
Description

US venture firm backing early-stage companies in healthcare, deep tech, and frontier science. Comparable to Sea Court Capital in leading concentrated, thesis-driven early-stage investments in healthcare innovation.

9OrbiMed
TypeDirect peer
Description

Healthcare-dedicated investment firm across venture, growth, and credit, with deep expertise in pharma services and healthcare infrastructure. Comparable to Sea Court Capital's healthcare-cold-chain focus area.

10New Enterprise Associates (NEA)
TypeBroad incumbent
Description

Large venture firm with significant healthcare and biotech exposure across stages. Comparable to Sea Court Capital as a healthcare-active early-stage investor, though operating at substantially larger scale and broader scope.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sea Court Capital

Venture Capitalseacourtcapital.com

Sea Court Capital firmographics

Firmographics
Name
Sea Court Capital
Legal name
Sea Court Capital
Website
https://seacourtcapital.com
Company type
Private
Founded year
2022
Operating status
Operating
Ownership category
akta.pro rank

Sea Court Capital industry classification

Industry
Product category
Venture Capital
NAICS
Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro primary industry
Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

Keywords

  • Venture capital investing
  • Healthcare technology investments
  • Cold chain logistics
  • Early-stage growth capital
  • Series A funding

Where Sea Court Capital is headquartered

Location

Headquarters

HQ city
Greenwich
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Sea Court Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Sea Court Capital product offering

Product offering

Core offering

Sea Court Capital is a venture capital firm that invests growth capital in early-stage companies developing cold chain logistics and healthcare technology solutions. The firm provides funding along with strategic guidance and industry connections to portfolio companies addressing temperature-controlled supply chain challenges in the pharmaceutical and healthcare sectors.

Product overview

Sea Court Capital is an investment/capital firm that provides venture capital funding to portfolio companies. The firm does not offer a technology product or service offering. Based on the source data, Sea Court Capital led the $16.5 million Series A funding round for Ember LifeSciences in December 2025 (later expanded to $27 million in May 2026). The company operates offices in Greenwich, CT, Washington, D.C., and Los Angeles, CA.

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-stage venture capital investment Venture capital funding deployed into early-stage companies developing cold chain logistics and healthcare technology solutions; investors receive equity stakes in exchange for growth capital.

Companies that use Sea Court Capital

Customer profile

Segments1 record

Ideal customer profiles1 record

Sea Court Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sea Court Capital partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Sea Court Capital competitors and assessment

Company assessment

Direct peers

  • Khosla Ventures: Large US venture firm with deep healthcare and life sciences practice alongside tech investing. Highly comparable to Sea Court Capital as an early-stage venture investor backing breakthrough healthcare and deep-tech solutions.
  • ARCH Venture Partners: Premier early-stage healthcare and life sciences venture firm that leads Series A rounds in biotech, pharma services, and healthtech infrastructure. Comparable to Sea Court Capital in leading thesis-driven healthcare investments at the Series A stage.
  • Flagship Pioneering: Venture firm that creates and funds breakthrough healthcare and biotech companies, with strong orientation toward platform innovations in pharma supply chain and life sciences infrastructure. Directly comparable to Sea Court Capital's healthcare-vertical thesis.
  • General Catalyst: Multi-stage venture firm with a substantial healthcare practice (Health Assurance) that invests in early- and growth-stage healthcare and pharma-services companies. Comparable as a thesis-driven VC backing healthcare logistics and infrastructure plays.
  • Section 32: Healthcare-focused venture fund investing in frontier healthtech, biotech, and pharma infrastructure at the Series A stage. Comparable to Sea Court Capital in leading specialized healthcare Series A rounds.
  • Lux Capital: US venture firm backing early-stage companies in healthcare, deep tech, and frontier science. Comparable to Sea Court Capital in leading concentrated, thesis-driven early-stage investments in healthcare innovation.
  • OrbiMed: Healthcare-dedicated investment firm across venture, growth, and credit, with deep expertise in pharma services and healthcare infrastructure. Comparable to Sea Court Capital's healthcare-cold-chain focus area.

Broad incumbents

  • Bessemer Venture Partners: Large multi-stage venture firm with a long-standing healthcare practice covering biotech, healthtech, and pharma services. Comparable as a healthcare-active VC, though broader in sector scope than Sea Court Capital's cold chain focus.
  • Andreessen Horowitz (a16z Bio + Health): Major venture firm with a dedicated bio/health fund investing in biotech, digital health, and healthcare infrastructure. Comparable as a healthcare-vertical lead investor, but operates at materially larger fund scale than Sea Court Capital.
  • New Enterprise Associates (NEA): Large venture firm with significant healthcare and biotech exposure across stages. Comparable to Sea Court Capital as a healthcare-active early-stage investor, though operating at substantially larger scale and broader scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Sea Court Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sea Court Capital leadership team

Management profile

Number of profiles

Sea Court Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sea Court Capital M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sea Court Capital

What does Sea Court Capital do?

Sea Court Capital is a venture capital firm that invests growth capital in early-stage companies developing cold chain logistics and healthcare technology solutions. The firm provides funding along with strategic guidance and industry connections to portfolio companies addressing temperature-controlled supply chain challenges in the pharmaceutical and healthcare sectors.

Is Sea Court Capital a public or private company?

Sea Court Capital is a private company. It is classified as unknown and is currently operating.

When was Sea Court Capital founded?

Sea Court Capital was founded in 2022.

Where is Sea Court Capital based?

Sea Court Capital is headquartered in Greenwich, United States, in the North America region.

Who are Sea Court Capital's main competitors?

Direct peers on record are Khosla Ventures, ARCH Venture Partners, Flagship Pioneering, General Catalyst, Section 32, Lux Capital and OrbiMed. Broad incumbents are Bessemer Venture Partners, Andreessen Horowitz (a16z Bio + Health) and New Enterprise Associates (NEA).

Does Sea Court Capital have an API?

No public API is recorded for Sea Court Capital.

What industry is Sea Court Capital in?

Sea Court Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAHAN, Corporate Strategic Real Assets & Infrastructure Venture Investing. Its NAICS code is 523 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceEmber LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in JapanEmber LifeSciences and Alfresa Corporation entered a capital and business alliance to improve pharmaceutical cold chain logistics in Japan. Alfresa will invest in Ember's Series A preferred stock and obtain exclusive sales rights in Japan's healthcare sector. The partnership aims to enhance Alfresa's Home Care Delivery service with Ember's temperature-controlled solutions.MorningstarEmber LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in JapanEmber LifeSciences and Alfresa Corporation entered a capital and business alliance to improve pharmaceutical cold chain logistics in Japan. Alfresa will invest in Ember's Series A preferred stock and obtain exclusive sales rights in Japan's healthcare sector. The partnership aims to enhance Alfresa's Home Care Delivery service with Ember's temperature-controlled solutions.Venture Capital Access OnlineEmber LifeSciences announces new strategic investments boosting Series A to $27MEmber LifeSciences announced strategic investments from Amgen Ventures and TDF Ventures, bringing its Series A funding to $27 million. The company also announced full commercial availability of the Ember Cube 2, a reusable cold chain solution. Financial terms were not disclosed.FinSMEsEmber LifeSciences Expand Series A to $27MEmber LifeSciences raised an undisclosed amount in Series A extension funding led by Amgen Ventures and TDF Ventures, bringing the total to $27M. The company will use the funds to expand operations and development efforts. It develops reusable digital shipping containers for cold-chain logistics.Castle PlacementTop 10 Manufacturing Capital Raises and Investors in the U.S.Castle Placement compiled a list of manufacturing capital raises in the U.S. for Q1 2026, covering ten transactions across PE growth, buyouts, mergers, and venture funding stages. Notable deals include Ember LifeSciences raising $37.44 million in Series A funding led by Sea Court Capital, Poynette IronWorks securing $20.9 million in venture funding, and Ultra Pouches closing $11 million in combined Series A rounds led by Left Lane Capital. Acquisitions included Aluma being acquired by Novae via Brightstar Capital Partners and Custom Glass Products being acquired by KI Wall.MarketScreenerEmber LifeSciences, Inc. announced that it has received $16.5 million in funding from Cardinal Health, Inc., Carrier Ventures, Sea Court Capital and other investorsEmber LifeSciences, Inc. closed a $16.5 million funding round on December 16, 2025, with participation from new investors Sea Court Capital and Cardinal Health, Inc., alongside returning investor Carrier Ventures and other individual investors. Sea Court Capital led the round as the primary lead investor. The capital will support Ember LifeSciences' operations and growth initiatives in the life sciences sector.GlobeNewswireCompass Point and Sea Court Management Announce Strategic PartnershipCompass Point and Sea Court Management announced a strategic partnership to combine investment banking and advisory services. Sea Court recently closed its Opportunity Fund I with $50 million in committed capital, targeting early- and mid-stage investments. The partnership aims to leverage both firms' sector expertise for capital raising and advisory.